Alternative donor HSCT for 109 children with acquired severe aplastic anemia:a single center retrospective analysis  

作　　者：LUO Chengjuan 罗成娟(Shanghai Jiaotong Univ,Sch Med,Shanghai Children's Med Center,Shanghai 200217)

机构地区：[1]Shanghai Jiaotong Univ,Sch Med,Shanghai Children's Med Center,Shanghai 200217

出　　处：《China Medical Abstracts(Internal Medicine)》2020年第2期114-115,共2页中国医学文摘（内科学分册（英文版）

摘　　要：Objective To investigate the efficacy of alternative donor(AD)in the treatment of aplastic anemia(AA)in children.Methods The clinical data of AA children who received AD HSCT in our center from Apr.2010 to Dec.2016 were retrospectively analyzed.The overall survival(OS)rate,implant success rate,incidence of acute and chronic graft・versus-host disease(GVHD)were statistically analyzed.Results A total of 109 children with acquired AA,including 64 severe AA(SAA),32 very severe AA(VSAA)and 13 transfusion dependent nonsevere AA(NSAA),were recruited in this retrospective AD HSCT study,the median age was 6(0.8-18)years old.

关 键 词：ANEMIA APLASTIC TRANSFUSION 

分 类 号：R725.5[医药卫生—儿科]